Healthcare -
Biotechnology - NASDAQ - US
$ 4.8325
124 %
$ 15 M
Market Cap
-0.15
P/E
BTAI - STOCK-BASED COMPENSATION
Stock-based Compensation BTAI - BioXcel Therapeutics, Inc.
18.6 M
LAST VALUE
-2.19%
2 YEAR CAGR
43.29%
5 YEAR CAGR
0.00%
10 YEAR CAGR